Monday, November 9, 2026

USD/EUR Bullish Momentum With A 1% Jump In The Last 10 Sessions

ViaNews Editorial Team

September 10, 2024

USD/EUR Bullish Momentum With A 1% Jump In The Last 10 Sessions

(VIANEWS) - USD/EUR (USDEUR) has been up by 1.31% for the last 10 sessions. At 06:08 EST on Tuesday, 10 September, USD/EUR (USDEUR) is $0.91.

USD/EUR's yearly highs and lows, it's 1.434% up from its 52-week low and 5.371% down from its 52-week high.

Volatility

USD/EUR's last week, last month's, and last quarter's current intraday variation average was a negative 0.01%, a negative 0.09%, and a positive 0.27%, respectively.

USD/EUR's highest amplitude of average volatility was 0.26% (last week), 0.34% (last month), and 0.27% (last quarter), respectively.

Forex Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, USD/EUR's Forex is considered to be oversold (<=20).

News about

  • Eur/usd struggles to lure buyers, remains below mid-1.1000s amid modest USD uptick. According to FXStreet on Tuesday, 10 September, "This assists the Greenback in attracting some buyers for the third successive day and climbing back closer to the monthly peak touched last week, which, in turn, is seen acting as a headwind for the EUR/USD pair.", "Apart from this, the crucial ECB policy decision on Thursday will provide a fresh directional impetus to the EUR/USD pair."
  • Eur/usd holds ground below 1.1100, faces challenges due to rising odds of ECB rate cut. According to FXStreet on Monday, 9 September, "However, the EUR/USD pair's upside may be capped, as recent eurozone inflation data have solidified expectations of a rate cut by the European Central Bank (ECB) at upcoming Thursday's policy meeting."
  • Eur/usd: trading a little lower – rabobank. According to FXStreet on Monday, 9 September, "Reflecting the movements in bond yields, there were a lot of gyrations in EUR/USD on Friday firstly on the back of the US payrolls report and then in response to the remarks of Fed speakers, Rabobank's Senior FX Strategist Jane Foley notes.", "As the market turns its attention to this week's events, which include the key US CPI inflation release, EUR/USD is trading a little lower. "
  • Eur/usd slips as ECB rate cut expectations weigh, drops below 1.1100. According to FXStreet on Monday, 9 September, "From a technical standpoint, the EUR/USD remains neutral to upward bias, though a decisive break below the September 3 low of 1.1026 might open the door for further downside. "

More news about USD/EUR (USDEUR).

ViaNews Editorial Team

Via News Editorial Team delivers comprehensive financial news coverage and market analysis from journalists around the world. Our team specializes in data journalism and in-depth reporting on stock markets, business developments, and economic trends.

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Q4 2026 Biotech Catalyst Cycle: Data Readouts, FDA Decisions and Capital-Allocation Shifts
From late October to January, mid-cap biotechs move through a dense run of events: ESMO and AHA/AASLD data presentations, Q3 earnings, and FDA PDUFA dates for ivonescimab (Nov 14) and lorundrostat (Dec 22). Alongside the regulatory news, companies are changing how they allocate capital: one lowered FY2026 R&D and SG&A guidance and pushed milestones into 2027, one authorized a $400M buyback, and one scheduled a delisting vote (EGM Nov 19, application Jan 25). Value is concentrating in a few binary regulatory and Phase 3 outcomes (Maritime-1 and ECLIPSE 2/3 readouts around Q1 2027), so sentiment is mixed.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Ford Motor Company
Both facts give cash for Ford Motor Company at the same point in time (2025-12-31; FY 2025 year-end and Q4 2025 year-end are the same date). Both are labelled USD, but the values are 23,356,000,000 and 23.356, which cannot both be true in USD. The two numbers agree once the second is read as billions (23.356 bn = 23,356,000,000), so the economic content is consistent and the conflict is a unit/scale error in the Q4 2025 record. The period is not the reason for the conflict: a Q4 and an FY figure at the same year-end date should match.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,996
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,996 facts checked against source5,558 source documents archived
Query this data → isubstrate.com